SHORT-TERM GAIN = LONG-TERM PAIN?
The latest blog by Jason Paltrowitz, EVP of Corporate Services, offers perspective on recent Reg A deals. The post on PubCoCEO.com discusses how the higher costs, time, regulatory burdens associated with executing an IPO on a U.S. stock exchange, and the recurring regulatory complexity of being exchange-listed, may not be the best solution for every company, especially small and micro-cap companies. Leave a comment.
OTC Market Tiers - Helping Investors Navigate the OTC Market
The Best Market
Discover Our Latest Insights
Join Our Blog
OTC MARKETS NEWS & UPDATES